Jonathan E. Mayhew

CIK 1806604 · View on SEC EDGAR ↗

Insider

First SEC filing: March 17, 2020 · Latest: March 17, 2020

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

4 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 26, 2020 CVS S 10b5-1 10,556 $65.00 $686,140 4,732 Direct -69.05% Disposed 47.1% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
April 1, 2020 CVS Stock Option Common Stock (28,159) — April 1, 2030 28,159 Acquired
April 1, 2020 CVS Stock Option Common Stock (28,159) — April 1, 2030 28,159 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 8 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
March 17, 2020 CVS Common Stock 13,537 Direct
March 17, 2020 CVS Common Stock (restricted) — Direct
March 17, 2020 CVS Common Stock (restricted) — Direct
March 17, 2020 CVS CVS Health Future Fund 401(k) Common Stock 408 Direct
March 17, 2020 CVS Stock Appreciation Rights→ Common Stock (6,634) 6,634 Direct
March 17, 2020 CVS Stock Appreciation Rights→ Common Stock (11,333) 11,333 Direct
March 17, 2020 CVS Stock Appreciation Rights→ Common Stock (3,067) 3,067 Direct
March 17, 2020 CVS Stock Option→ Common Stock (44,037) 44,037 Direct